InQpharm Group
🇲🇾Malaysia
- Country
- 🇲🇾Malaysia
- Ownership
- Private
- Established
- 2004-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.inqpharm.com
Benefit and Tolerability of IQP-LU-104 in Weight Loss
Not Applicable
Completed
- Conditions
- ObesityOverweight
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: Low dose IQP-LU-104 (2560mg)Dietary Supplement: High dose IQP-LU-104 (5120mg)
- First Posted Date
- 2019-03-25
- Last Posted Date
- 2022-08-03
- Lead Sponsor
- InQpharm Group
- Target Recruit Count
- 108
- Registration Number
- NCT03888911
- Locations
- 🇩🇪
Analyze & Realize, Berlin, Germany
Clinical Benefit of a Mouthrinse for the Treatment of Dentine Hypersensitivity
Not Applicable
Completed
- Conditions
- Dentin Sensitivity
- Interventions
- Other: Mouthrinse (IQP-OLP-101)
- First Posted Date
- 2017-07-27
- Last Posted Date
- 2018-01-03
- Lead Sponsor
- InQpharm Group
- Target Recruit Count
- 30
- Registration Number
- NCT03232255
- Locations
- 🇩🇪
Praxisklinik ORS, Fellbach, Germany
Efficacy and Safety of Litramine in 1 Year Weight Loss Study
Not Applicable
Completed
- Conditions
- Obesity; Excess CaloriesOverweight and ObesityWeight Loss
- Interventions
- Dietary Supplement: Placebo tabletDietary Supplement: Litramine
- First Posted Date
- 2017-07-24
- Last Posted Date
- 2020-02-28
- Lead Sponsor
- InQpharm Group
- Target Recruit Count
- 166
- Registration Number
- NCT03227276
- Locations
- 🇩🇪
Analyze & Realize, Berlin, Germany
Benefit of IQP-AO-101 for Sleep
Not Applicable
Completed
- Conditions
- Insomnia, Nonorganic
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: IQP-AO-101
- First Posted Date
- 2017-04-14
- Last Posted Date
- 2018-01-03
- Lead Sponsor
- InQpharm Group
- Target Recruit Count
- 50
- Registration Number
- NCT03114696
- Locations
- 🇩🇪
Analyze & Realize, Berlin, Germany
Benefit and Tolerability of IQP-AE-103 in Weight Loss
Not Applicable
Completed
- Conditions
- OverweightObesity
- Interventions
- Dietary Supplement: IQP-AE-103 (330mg)Dietary Supplement: IQP-AE-103 (165mg)Dietary Supplement: Placebo
- First Posted Date
- 2017-02-20
- Last Posted Date
- 2018-01-03
- Lead Sponsor
- InQpharm Group
- Target Recruit Count
- 108
- Registration Number
- NCT03058367
- Locations
- 🇩🇪
Analyze & Realize, Berlin, Germany
Efficacy of Glucosanol™ in Reducing Post-prandial Glucose Levels in Overweight Subjects
Not Applicable
Completed
- Conditions
- Hyperglycemia, Postprandial
- Interventions
- Dietary Supplement: Glucosanol 500mgDietary Supplement: Placebo
- First Posted Date
- 2016-10-12
- Last Posted Date
- 2017-02-08
- Lead Sponsor
- InQpharm Group
- Target Recruit Count
- 24
- Registration Number
- NCT02930681
- Locations
- 🇩🇪
analyze & realize GmbH, Berlin, Germany
Efficacy and Safety of Glucosanol™ in Body Weight Reduction
Not Applicable
Completed
- Conditions
- Overweight and Obesity
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: Glucosanol 500mgDietary Supplement: Glucosanol 350mg
- First Posted Date
- 2016-10-12
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- InQpharm Group
- Target Recruit Count
- 90
- Registration Number
- NCT02930668
- Locations
- 🇩🇪
Barbara Grube, Berlin, Germany
Influence of IQPAS-119 on Post-Marathon Susceptibility to Infections and Others
Not Applicable
Completed
- Conditions
- Upper Respiratory Tract Symptoms
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: IQP-AS-119
- First Posted Date
- 2016-08-22
- Last Posted Date
- 2018-01-03
- Lead Sponsor
- InQpharm Group
- Target Recruit Count
- 75
- Registration Number
- NCT02873910
- Locations
- 🇩🇪
analyze & realize GmbH, Berlin, Germany
Vasoactive Effects of IQP-AS-118 in Healthy Individuals
Not Applicable
Withdrawn
- Conditions
- Blood FlowCardiovascular Disease
- Interventions
- Dietary Supplement: IQP-AS-118Dietary Supplement: Placebo
- First Posted Date
- 2016-08-18
- Last Posted Date
- 2020-02-12
- Lead Sponsor
- InQpharm Group
- Registration Number
- NCT02871310
- Locations
- 🇩🇪
analyze & realize GmbH, Berlin, Germany
Tolerability and Benefit of IQP-AS-121 on Fatigue and Mental Alertness
Not Applicable
Withdrawn
- Conditions
- Fatigue
- Interventions
- Dietary Supplement: IQP-AS-121
- First Posted Date
- 2016-08-18
- Last Posted Date
- 2020-02-12
- Lead Sponsor
- InQpharm Group
- Registration Number
- NCT02871271
- Locations
- 🇩🇪
analyze & realize GmbH, Berlin, Germany
© Copyright 2025. All Rights Reserved by MedPath